Theravance Biopharma, Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. FDX
3. ABBV
4. META
5. SPY
6. ACN
7. BLZE
8. IBM
9. NKE
10. MU

Go back to Theravance Biopharma, Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update

Theravance Biopharma (TBPH) Tops Q2 EPS by 44c, Revenues Beat

August 1, 2018 7:11 AM EDT

Theravance Biopharma (NASDAQ: TBPH) reported Q2 EPS of ($0.76), $0.44 better than the analyst estimate of ($1.20). Revenue for the quarter came in at $23.75 million versus the consensus estimate of $10.67 million.

Rick E Winningham, Chairman and Chief Executive Officer, commented: "We have made exciting progress... More